SEC Form 4

FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5
X	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person* Aberdare Ventures II, L.P. (Last) (First) (Middle) ONE EMBARCADERO CENTER SUITE 4000 (Street) SAN FRANCISCO CA 94111 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol Anacor Pharmaceuticals Inc [ ANAC ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director X 10% Owner Officer (give title below) Other (specify below)
	3. Date of Earliest Transaction (Month/Day/Year) 11/30/2010
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) Form filed by One Reporting Person X Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/30/2010		C		324,975	A	(1)	324,975	I	See Footnote(3)
Common Stock	11/30/2010		C		337,831	A	(2)	662,806	I	See Footnote(4)
Common Stock	11/30/2010		C		593,697	A	(1)	1,256,503	I	See Footnote(5)
Common Stock	11/30/2010		C		95,788	A	(1)	1,352,291	I	See Footnote(6)
Common Stock	11/30/2010		C		99,645	A	(1)	1,451,936	I	See Footnote(7)
Common Stock	11/30/2010		P		300,000	A	$5	1,751,936	I	See Footnote(8)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Series A-1 Preferred Stock	(1)	11/30/2010		C			324,975	(1)	(1)	Common Stock	324,975	$0	0	I	See Footnote(3)
Series B Preferred Stock	(2)	11/30/2010		C			256,651	(2)	(2)	Common Stock	337,831	$0	0	I	See Footnote(4)
Series C Preferred Stock	(1)	11/30/2010		C			593,697	(1)	(1)	Common Stock	593,697	$0	0	I	See Footnote(5)
Series D Preferred Stock	(1)	11/30/2010		C			95,788	(1)	(1)	Common Stock	95,788	$0	0	I	See Footnote(6)
Series E Preferred Stock	(1)	11/30/2010		C			99,645	(1)	(1)	Common Stock	99,645	$0	0	I	See Footnote(7)

1. Name and Address of Reporting Person* Aberdare Ventures II, L.P. (Last) (First) (Middle) ONE EMBARCADERO CENTER SUITE 4000 (Street) SAN FRANCISCO CA 94111 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* Aberdare Ventures II (Bermuda), L.P. (Last) (First) (Middle) ONE EMBARCADERO CENTER SUITE 4000 (Street) SAN FRANCISCO CA 94111 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* ABERDARE II ANNEX FUND L P (Last) (First) (Middle) ONE EMBARCADERO CENTER SUITE 4000 (Street) SAN FRANCISCO CA 94111 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* Aberdare GP II, L.L.C. (Last) (First) (Middle) ONE EMBARCADERO CENTER SUITE 4000 (Street) SAN FRANCISCO CA 94111 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

Explanation of Responses:

1. The Series A-1 Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series E Preferred Stock converted into Common Stock on a 1-for-1 basis and had no expiration date.

2. The Series B Preferred Stock converted into Common Stock on the basis of 1.316 shares of Common Stock for one share of Series B Preferred Stock and had no expiration date.

3. Consists of 7,203 shares held by Aberdare Ventures II, L.P. ("Aberdare Bermuda") and 317,772 shares held be Aberdare Ventures II, L.P. ("Aberdare II"). Aberdare GP II, L.L.C. ("Aberdare GP II") serves as the sole General Partner of Aberdare Bermuda and Aberdare II, and has sole voting and investment control over the shares owned by Aberdare Bermuda and Aberdare II, and may be deemed to own beneficially the shares held by Aberdare Bermuda and Aberdare II. Aberdare GP II however owns no securities of the Issuer directly. Paul H. Klingenstein ("Klingenstein") is the Manager of Aberdare GP II and has voting and dispositive power over the shares held by Aberdare Bermuda and Aberdare II. Klingenstein disclaims beneficial ownership of the reportable securities, except to the extent of his pecuniary interest therein. Klingenstein is a director of the Issuer and, accordingly, files separate Section 16 reports.

4. Consists of 7,488 shares held by Aberdare Bermuda. and 330,343 shares held be Aberdare II. Aberdare GP II serves as the sole General Partner of Aberdare Bermuda and Aberdare II, and has sole voting and investment control over the shares owned by Aberdare Bermuda and Aberdare II, and may be deemed to own beneficially the shares held by Aberdare Bermuda and Aberdare II. Aberdare GP II however owns no securities of the Issuer directly. Klingenstein is the Manager of Aberdare GP II and has voting and dispositive power over the shares held by Aberdare Bermuda and Aberdare II. Klingenstein disclaims beneficial ownership of the reportable securities, except to the extent of his pecuniary interest therein. Klingenstein is a director of the Issuer and, accordingly, files separate Section 16 reports.

5. Consists of 13,160 shares held by Aberdare Bermuda and 580,537 shares held be Aberdare II. Aberdare GP II serves as the sole General Partner of Aberdare Bermuda and Aberdare II, and has sole voting and investment control over the shares owned by Aberdare Bermuda and Aberdare II, and may be deemed to own beneficially the shares held by Aberdare Bermuda and Aberdare II. Aberdare GP II however owns no securities of the Issuer directly. Klingenstein is the Manager of Aberdare GP II and has voting and dispositive power over the shares held by Aberdare Bermuda and Aberdare II. Klingenstein disclaims beneficial ownership of the reportable securities, except to the extent of his pecuniary interest therein. Klingenstein is a director of the Issuer and, accordingly, files separate Section 16 reports.

6. Consists of 2,123 shares held by Aberdare Bermuda and 93,665 shares held be Aberdare II. Aberdare GP II serves as the sole General Partner of Aberdare Bermuda and Aberdare II, and has sole voting and investment control over the shares owned by Aberdare Bermuda and Aberdare II, and may be deemed to own beneficially the shares held by Aberdare Bermuda and Aberdare II. Aberdare GP II however owns no securities of the Issuer directly. Klingenstein is the Manager of Aberdare GP II and has voting and dispositive power over the shares held by Aberdare Bermuda and Aberdare II. Klingenstein disclaims beneficial ownership of the reportable securities, except to the extent of his pecuniary interest therein. Klingenstein is a director of the Issuer and, accordingly, files separate Section 16 reports.

7. Consists of 99,645 shares held by Aberdare II Annex Fund, L.P. ("Aberdare Annex"). Aberdare GP II serves as the sole General Partner of Aberdare Annex, and has sole voting and investment control over the shares owned by Aberdare Annex, and may be deemed to own beneficially the shares held by Aberdare Annex. Aberdare GP II however owns no securities of the Issuer directly. Klingenstein is the Manager of Aberdare GP II and has voting and dispositive power over the shares held by Aberdare Annex. Klingenstein disclaims beneficial ownership of the reportable securities, except to the extent of his pecuniary interest therein. Klingenstein is a director of the Issuer and, accordingly, files separate Section 16 reports.

8. Consists of 300,000 shares held by Aberdare Annex. Aberdare GP II serves as the sole General Partner of Aberdare Annex, and has sole voting and investment control over the shares owned by Aberdare Annex, and may be deemed to own beneficially the shares held by Aberdare Annex. Aberdare GP II however owns no securities of the Issuer directly. Klingenstein is the Manager of Aberdare GP II and has voting and dispositive power over the shares held by Aberdare Annex. Klingenstein disclaims beneficial ownership of the reportable securities, except to the extent of his pecuniary interest therein. Klingenstein is a director of the Issuer and, accordingly, files separate Section 16 reports.

	Aberdare Ventures II, L.P., By Aberdare GP II, L.L.C., Its General Partner, /s/ Paul H. Klingenstein, Manager	11/30/2010
	Aberdare Ventures II (Bermuda), L.P. By Aberdare GP II, L.L.C., Its General Partner, /s/ Paul H. Klingenstein, Manager	11/30/2010
	Aberdare II Annex Fund, L.P. By Aberdare GP II, L.L.C., Its General Partner, /s/ Paul H. Klingenstein, Manager	11/30/2010
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.